J Korean Med Assoc.  2015 Oct;58(10):873-877. 10.5124/jkma.2015.58.10.873.

Geriatric considerations in the diagnosis and management of lower urinary tract dysfunction

• Kim YT

• KMID: 2195101
• DOI: http://doi.org/10.5124/jkma.2015.58.10.873

Abstract

Lower urinary tract dysfunction increases with age. Detrusor overactivity, detrusor underactivity, and detrusor hyperreflexia with impaired contractility are more common in elderly population. The elderly patients usually have cormobidities, comedications, and precipitation factors, which cause or exacerbate urinary symptoms, or aggravate subclinical lower urinary tract dysfunction to overwhelming diseases. Pharmacokinetics and pharmacodynamics changes with age. Older patients may refuse appropriate therapy because they are concerned about adverse effects, and economic burden. Thus strategy for the diagnosis and the management of lower urinary tract dysfunction in elderly might be different from those in young population. The diagnostic evaluation of these patients starts with history taking and non-invasive tests to make a plan to treat patient's symptom. Watchful waiting with lifestyle intervention is a good treatment modality. If pharmacotheraphy is planned, it would be better to start with low dose, then escalate dose. Adverse effects of medications are more common in elderly patients not by old age, but by comorbidity and comedication. First follow up might be in a short period after prescription when adverse effects usually occur.

Keyword

Geriatrics; Lower urinary tract symptoms; Drug therapy

MeSH Terms

Aged
Comorbidity
Diagnosis*
Drug Therapy
Follow-Up Studies
Geriatrics
Humans
Life Style
Lower Urinary Tract Symptoms
Pharmacokinetics
Prescriptions
Reflex, Abnormal
Urinary Tract*
Watchful Waiting

Reference

1. Nuotio M, Tammela TL, Luukkaala T, Jylha M. Urgency and urge incontinence in an older population: ten-year changes and their association with mortality. Aging Clin Exp Res. 2002; 14:412–419.

2. Nakagawa H, Niu K, Hozawa A, Ikeda Y, Kaiho Y, Ohmori-Matsuda K, Nakaya N, Kuriyama S, Ebihara S, Nagatomi R, Tsuji I, Arai Y. Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study. J Urol. 2010; 184:1413–1418.

3. Brown JS, Vittinghoff E, Wyman JF, Stone KL, Nevitt MC, Ensrud KE, Grady D. Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc. 2000; 48:721–725.

4. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001; 87:760–766.

5. Haferkamp A, Elbadawi A. Ultrastructural changes in the aging bladder. Urologe A. 2004; 43:527–534.

6. Elbadawi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity. J Urol. 1993; 150(5 Pt 2):1668–1680.

7. Mansfield KJ, Liu L, Mitchelson FJ, Moore KH, Millard RJ, Burcher E. Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing. Br J Pharmacol. 2005; 144:1089–1099.

8. Jeong SJ, Kim HJ, Lee YJ, Lee JK, Lee BK, Choo YM, Oh JJ, Lee SC, Jeong CW, Yoon CY, Hong SK, Byun SS, Lee SE. Prevalence and clinical features of detrusor underactivity among elderly with lower urinary tract symptoms: a comparison between men and women. Korean J Urol. 2012; 53:342–348.

9. Abrams P, Chapple C, Khoury S, Roehrborn C, de la Rosette J. International Scientific Committee. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2009; 181:1779–1787.

10. Wullner U, Schmitz-Hubsch T, Antony G, Fimmers R, Spottke A, Oertel WH, Deuschl G, Klockgether T, Eggert K. KNP e.V.Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing. Eur J Neurol. 2007; 14:1405–1408.

11. Baztan JJ, Arias E, Gonzalez N, Rodriguez de Prada MI. New-onset urinary incontinence and rehabilitation outcomes in frail older patients. Age Ageing. 2005; 34:172–175.

12. DuBeau CE, Kuchel GA, Johnson T 2nd, Palmer MH, Wagg A. Fourth International Consultation on Incontinence. Incontinence in the frail elderly: report from the 4th International Consultation on Incontinence. Neurourol Urodyn. 2010; 29:165–178.

13. Bang WJ, Lee JY, Koo KC, Hah YS, Lee DH, Cho KS. Is type-2 diabetes mellitus associated with overactive bladder symptoms in men with lower urinary tract symptoms? Urology. 2014; 84:670–674.

14. Dubeau CE. The aging lower urinary tract. J Urol. 2006; 175(3 Pt 2):S11–S15.

15. Chiu AF, Liao CH, Wang CC, Wang JH, Tsai CH, Kuo HC. High classification of chronic heart failure increases risk of overactive bladder syndrome and lower urinary tract symptoms. Urology. 2012; 79:260–265.

16. Wallin A, Sjogren M, Edman A, Blennow K, Regland B. Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia. Eur Neurol. 2000; 44:229–235.

17. Wodchis WP, Teare GF, Anderson GM. Cost and quality: evidence from Ontario long term care hospitals. Med Care. 2007; 45:981–988.

18. Pfisterer MH, Johnson TM 2nd, Jenetzky E, Hauer K, Oster P. Geriatric patients' preferences for treatment of urinary incontinence: a study of hospitalized, cognitively competent adults aged 80 and older. J Am Geriatr Soc. 2007; 55:2016–2022.

19. Teunissen TA, de Jonge A, van Weel C, Lagro-Janssen AL. Treating urinary incontinence in the elderly: conservative thera-pies that work: a systematic review. J Fam Pract. 2004; 53:25–30. 32

20. Van Houten P, Achterberg W, Ribbe M. Urinary incontinence in disabled elderly women: a randomized clinical trial on the effect of training mobility and toileting skills to achieve independent toileting. Gerontology. 2007; 53:205–210.

21. Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ. 2006; 332:455–459.

22. Kay G, Crook T, Rekeda L, Lima R, Ebinger U, Arguinzoniz M, Steel M. Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. Eur Urol. 2006; 50:317–326.

23. Wagg A, Verdejo C, Molander U. Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder. Int J Clin Pract. 2010; 64:1279–1286.

24. Wagg A, Khullar V, Marschall-Kehrel D, Michel MC, Oelke M, Darekar A, Bitoun CE, Weinstein D, Osterloh I. Flexible-dose fesoterodine in elderly adults with overactive bladder: results of the randomized, double-blind, placebo-controlled study of fesoterodine in an aging population trial. J Am Geriatr Soc. 2013; 61:185–193.

25. Laroche ML, Charmes JP, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol. 2007; 63:177–186.

26. Thorne MB, Geraci SA. Acute urinary retention in elderly men. Am J Med. 2009; 122:815–819.

27. Pfisterer MH, Griffiths DJ, Schaefer W, Resnick NM. The effect of age on lower urinary tract function: a study in women. J Am Geriatr Soc. 2006; 54:405–412.

28. Rembratt A, Riis A, Norgaard JP. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia. Neurourol Urodyn. 2006; 25:105–109.

29. Campeau L, Tu LM, Lemieux MC, Naud A, Karsenty G, Schick E, Corcos J. A multicenter, prospective, randomized clinical trial comparing tension-free vaginal tape surgery and no treatment for the management of stress urinary incontinence in elderly women. Neurourol Urodyn. 2007; 26:990–994.

30. Dalpiaz O, Primus G, Schips L. SPARC sling system for treatment of female stress urinary incontinence in the elderly. Eur Urol. 2006; 50:826–830.

31. Jiang YH, Liao CH, Tang DL, Kuo HC. Efficacy and safety of intravesical onabotulinumtoxinA injection on elderly patients with chronic central nervous system lesions and overactive bladder. PLoS One. 2014; 9:e105989.